TNXP: Tonix Pharmaceuticals Holding Corp. Stock

by  •  • Comments Off on TNXP: Tonix Pharmaceuticals Holding Corp. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 19.65
Enterprise Value ($M) 23.99
Book Value ($M) 42.10
Book Value / Share 0.30
Price / Book 0.47
NCAV ($M) -2.92
NCAV / Share -0.02
Price / NCAV -6.74

Profitability (mra)
Return on Invested Capital (ROIC) -2.90
Return on Assets (ROA) -1.07
Return on Equity (ROE) -1.23

Liquidity (mrq)
Quick Ratio 0.72
Current Ratio 1.15

Balance Sheet (mrq) ($M)
Current Assets 25.29
Assets 70.31
Liabilities 28.20
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
06-20 13G L1 Capital Global Opportunities Master Fund, Ltd. 9.99
02-14 13G Alyeska Investment Group, L.P. 9.99
02-14 13G Armistice Capital, Llc 6.71
02-14 13G/A Tang Capital Partners Lp 0.00
01-11 13G Empery Asset Management, LP 9.99
01-03 13G Sabby Management, Llc 9.99

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT P
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-10-11 2,528,233 6,059,330 41.72
2024-10-10 3,997,125 10,778,445 37.08
2024-10-09 5,549,955 14,073,112 39.44
2024-10-08 13,869,645 30,437,272 45.57

(click for more detail)

Similar Companies
TIL – Instil Bio, Inc. TLSA – Tiziana Life Sciences Ltd
TNFA – TNF Pharmaceuticals, Inc. TPST – Tempest Therapeutics, Inc.
TRAW – Traws Pharma, Inc.


Financial data and stock pages provided by
Fintel.io